健康科学ジャーナル

  • ISSN: 1108-7366
  • ジャーナル h-index: 51
  • 雑誌引用スコア: 10.69
  • ジャーナルのインパクトファクター: 9.13
インデックス付き
  • Genamics JournalSeek
  • 中国国家知識基盤 (CNKI)
  • サイテファクター
  • シナール完了
  • シマゴ
  • 電子ジャーナルライブラリ
  • 研究ジャーナル索引作成ディレクトリ (DRJI)
  • EMケア
  • OCLC-WorldCat
  • 大学補助金委員会
  • ジュネーブ医学教育研究財団
  • ユーロパブ
  • Google スカラー
  • シェルパ・ロメオ
  • 秘密検索エンジン研究所
このページをシェアする

抽象的な

N-linked Glycosylation and its Potential Application in Drug Development

Shilei Wang, Quanyong He, Jinlei Ye, Zhichao Kang, Qiping Zheng, Shuo Liu, Jun He and Lichun Sun

Protein glycosylation is a site-specific enzymatic process to attach oligosaccharides or carbohydrates to proteins. N-linked glycosylation (N-glycosylation) is the major type of glycosylation for the post-translational and co-translational modification of proteins in eukaryotic cells. N-linked glycosylation is to link saccharide molecules to proteins via covalently coupling oligosaccharides or glycans to the amino acid residue asparagine (Asn, N) of proteins, mostly with the requirement of a Asn–X–Ser/Thr (N-X-S/T) consensus sequence. N-linked protein glycosylation is of significance and plays critical roles in biological and pathological processes, and also applied for modern drug development. Particularly, the strategy to engineer N-linked glycosylation site(s) can stabilize the recombinant fusion proteins. This technology has been widely applied for drug discovery, especially for the peptide drugs such as rabies viral glycoprotein (RVG), cardiac-targeting peptide (CTP), bovine adrenal medulla (BAM).